Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma
Clinical trial NCT00596154 · COMPLETED
Trial details
- NCT number
- NCT00596154
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2023-02-02
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.